l carnitine valproic acid toxicity Deficiency: What Is It, Causes, Symptoms, and More Reversible weakness and encephalopathy while
Description
NIH Office of Dietary Supplements
Cystine-glutamate antiporter
However, the improvement of the histological markers suggests that the heart was successfully protected by the L-carnitine treatment
, , L- 2-
In addition, participants in the L-Carnitine-combination group were on average older than those in the placebo group, which may account for the lower (albeit not significant) baseline values observed in the 6-min walk test
Int J Mol Sci 21: 3369, 2020
